84 related articles for article (PubMed ID: 12907238)
1. Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females.
Calvert RJ; Tepper S; Diwan BA; Anderson LM; Kritchevsky D
Biochem Pharmacol; 2003 Aug; 66(3):393-403. PubMed ID: 12907238
[TBL] [Abstract][Full Text] [Related]
2. Alterations in membrane-bound and cytoplasmic K-ras protein levels in mouse lung induced by treatment with lovastatin, cholestyramine, or niacin: effects are highly mouse strain dependent.
Calvert RJ; Ramakrishna G; Tepper S; Diwan BA; Anderson LM; Kritchevsky D
Biochem Pharmacol; 2002 Jul; 64(1):41-8. PubMed ID: 12106604
[TBL] [Abstract][Full Text] [Related]
3. Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain.
Calvert RJ; Tepper S; Kammouni W; Anderson LM; Kritchevsky D
Biochem Pharmacol; 2006 Dec; 72(12):1749-55. PubMed ID: 17005160
[TBL] [Abstract][Full Text] [Related]
4. Levels and membrane localization of the c-K-ras p21 protein in lungs of mice of different genetic strains and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Aroclor 1254.
Ramakrishna G; Anderson LM
Carcinogenesis; 1998 Mar; 19(3):463-70. PubMed ID: 9525281
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin.
Hawk MA; Cesen KT; Siglin JC; Stoner GD; Ruch RJ
Cancer Lett; 1996 Dec; 109(1-2):217-22. PubMed ID: 9020924
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
7. Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin.
Chang MY; Jan MS; Won SJ; Liu HS
Biochem Biophys Res Commun; 1998 Jul; 248(1):62-8. PubMed ID: 9675086
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
9. [In vitro effect of lovastatin on NB4 promyelocytic leukemia cells].
Guo F; Cen J; Chen Z
Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):584-8. PubMed ID: 11855147
[TBL] [Abstract][Full Text] [Related]
10. Improvement in arterial stiffness during hypolipidaemic therapy is offset by weight gain.
Matthews PG; Wahlqvist ML; Marks SJ; Myers KA; Hodgson JM
Int J Obes Relat Metab Disord; 1993 Oct; 17(10):579-83. PubMed ID: 8242126
[TBL] [Abstract][Full Text] [Related]
11. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
[TBL] [Abstract][Full Text] [Related]
12. Increased cellular triglyceride levels in human monocytic and rat smooth muscle cells after lovastatin.
Hrboticky N; Becker A; Kruse HJ; Weber PC
Biochim Biophys Acta; 1997 Nov; 1349(3):211-21. PubMed ID: 9434135
[TBL] [Abstract][Full Text] [Related]
13. A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors.
Mira E; Carmona-Rodríguez L; Tardáguila M; Azcoitia I; González-Martín A; Almonacid L; Casas J; Fabriás G; Mañes S
Oncotarget; 2013 Dec; 4(12):2288-301. PubMed ID: 24317954
[TBL] [Abstract][Full Text] [Related]
14. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation.
Wang IK; Lin-Shiau SY; Lin JK
Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Zhong WB; Wang CY; Chang TC; Lee WS
Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
[TBL] [Abstract][Full Text] [Related]
16. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.
Jackson JH; Cochrane CG; Bourne JR; Solski PA; Buss JE; Der CJ
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3042-6. PubMed ID: 2183224
[TBL] [Abstract][Full Text] [Related]
17. Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
Schulman KA; Kinosian B; Jacobson TA; Glick H; Willian MK; Koffer H; Eisenberg JM
JAMA; 1990 Dec; 264(23):3025-33. PubMed ID: 2123013
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle-specific effects of lovastatin.
Jakóbisiak M; Bruno S; Skierski JS; Darzynkiewicz Z
Proc Natl Acad Sci U S A; 1991 May; 88(9):3628-32. PubMed ID: 1673788
[TBL] [Abstract][Full Text] [Related]
19. [Study on the effects of the hypocholesteremic agents, cholestyramine and compactin on the induction of renal tumors in rats by N-ethyl-N-hydroxyethyl nitrosamine].
Hashimoto S
Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):75-84. PubMed ID: 1564828
[TBL] [Abstract][Full Text] [Related]
20. Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression.
Jones-Bolin SE; Johansson E; Palmisano WA; Anderson MW; Wiest JS; Belinsky SA
Carcinogenesis; 1998 Aug; 19(8):1503-8. PubMed ID: 9744549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
